When:
May 14, 2014 @ 12:45 pm – 8:00 pm
2014-05-14T12:45:00+00:00
2014-05-14T20:00:00+00:00
Where:
Yale University West Campus
West Campus Drive
West Haven, CT 06516
USA
Cost:
Free

The Yale Diabetes Research Center announces a Pan-Connecticut Symposium dedicated to “Innovative Approaches to Diabetes Research and Therapies”, co-sponsored by Yale University and the University of Connecticut, in cooperation with The Jackson Laboratory, and in coordination with the JDRF.
Topics to be covered include: immunologic mechanisms and therapies, microbiota-metabolic interactions, beta cell differentiation, cell biology, CNS control of metabolism, and the pathogenesis of diabetes and obesity. A parallel goal of the symposium is to serve as a precursor to the creation of the “Connecticut Center for Metabolic Disease Research” (CCMDR), a multi-institutional collaborative effort with an emphasis on diabetes (T1D and T2D) research.

NO CHARGE FOR ATTENDANCE, RSVP IS REQUESTED (email to kathleen.catalano@yale.edu)

AGENDA:

9:00-9:15 AM
Welcome and Introduction
(Dr. Milton Wallack)

MODERATOR:  Haifan Lin, PhD

9:15-9:45 am
Robert Sherwin, MD
“The Brain-Diabetes Connection

9:45-10:15 am
Kevan Herold, MD
“Progression of Type 1 diabetes in those at risk”

10:15-10:30 am
Coffee Break

10:30-11:00 am
Nancy Petry, PhD
UCONN
“A reinforcement intervention to improve diabetes management”

11:00-11:30 am
Matthew Rodeheffer, PhD
“Adipocyte stem cells and metabolic disease/diabetes: Beyond adipose tissue”

11:30 am-12 noon
Richard Flavell, PhD
“Dysbiosis and diabetes”

12:00-1:30 pm
Lunch and Poster session

MODERATOR: Marc Lalande, PhD

1:30-2:00 pm
Ruslan Medzhitov, PhD
“Homeostasis and inflammation”

2:00-2:30 pm
Michael Stitzel, PhD
Jackson Labs
“Islet epigenome, stretch enhancers, and type 2 diabetes GWAS”

2:30-3:00 pm
George Weinstock, PhD
Jackson Labs
“The human microbiome and disease”

3:00-3:30 pm
Gerald Shulman, MD, PhD
“Cellular mechanisms of insulin resistance: Implications for obesity, lipodystrophy, type 2 diabetes and the metabolic syndrome”

3:30-4:00 pm
DISCUSSION

MODERATOR: Robert Sherwin, MD